NCT01675427View on ClinicalTrials.gov

A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C

PHASE4CompletedINTERVENTIONAL
Enrollment

4,766

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Hepatitis C, Chronic
Interventions
OTHER

Interleukin 28B testing

Blood sampling for ILB28 genotyping

Trial Locations (210)

11

Lima

50

Baabda

100

Taipei

112

Taipei

333

Taoyuan District

807

Kaohsiung City

1000

Brussels

Skopje

1006

Riga

1010

Caracas

1020

Brussels

1060

Caracas

1070

Brussels

1073

Caracas

1080

Caracas

1090

Brussels

1180

Brussels

1190

Brussels

2060

Antwerp

2650

Edegem

3000

Leuven

3500

Hasselt

3600

Genk

4000

Liège

4005

Maracaibo

4077

Safat

4545

Dubai

4802

Heusy

6448

Aleppo

6900

Lugano

7600

Mar del Plata

8000

Bruges

8400

Ostend

8500

Kortrijk

8800

Roeselare

9000

Ghent

9007

Sankt Gallen

10082

Cuorgnè (TO)

10138

Tallinn

10243

Berlin

10617

Tallinn

10777

Berlin

11000

Belgrade

11522

Athens

11527

Athens

11559

Cairo

13385

Marseille

13900

Biella

14050

Mexico City

14564

Nea Kifissia

15236

Frankfurt (Oder)

16132

Genoa

17100

Savona

18057

Rostock

20021

Lahore

20122

Milan

20123

Milan

20132

Milan

20142

Milan

20157

Milan

20162

Milan

21000

Novi Sad

22304

Alexandria

22450

Tijuana

23562

Lübeck

26480

Eskişehir

28887

Omegna (VB)

29121

Piacenza

31025

Kohtla-Järve

31040

Hatay

31059

Toulouse

32511

Menoufiya

33100

Udine

33169

Mersin

33604

Pessac

34117

Kassel

34390

Istanbul

35033

Rennes

35100

Izmir

35128

Padua

35144

Panevezys

36019

Châteauroux

38039

Kayseri

39120

Magdeburg

40138

Bologna

40237

Düsseldorf

40447

Taichung

41100

Modena

43126

Parma

45122

Essen

47116

Kaunas

50009

Kaunas

50134

Florence

50937

Cologne

51014

Tartu

52074

Aachen

52100

Arezzo

54511

Vandœuvre-lès-Nancy

55139

Samsun

57124

Livorno

59037

Lille

60020

Torrette Di Ancona

60250

Tokat Province

61080

Trabzon

65185

Karlstad

66013

Chieti

67091

Strasbourg

68100

Alexandroupoli

68167

Mannheim

69317

Lyon

70013

Castellana Grotte

70052

Bisceglie

70124

Bari

71013

San Giovanni Rotondo

72076

Tübingen

72108

Rottenburg

75185

Uppsala

75571

Paris

75679

Paris

76031

Rouen

76231

Šiauliai

80010

Pärnu

80035

Nola

80054

Gragnano

80131

Napoli

80136

Napoli

80138

Napoli

80187

Gävle

80220

Culiacán

81025

Marcianise

83100

Avellino

84014

Nocera Inferiore

84489

Burghausen

84902

Avignon

89100

Reggio Calabria

90127

Palermo

91054

Erlangen

92288

Klaipėda

94010

Créteil

95100

Catania

95126

Catania

98124

Messina

99999

Beirut

293406

Timișoara

300167

Timișoara

400162

Cluj-Napoca

700554

Iași

700620

Iași

8330024

Santiago

8380456

Santiago

CP B1704 ETD

Buenos Aires

Unknown

Cairo

Giza

Tanta

Beirut

Nabatieh

Faisalabad

Gujranwala

Karachi

Lahore

Rawalpindi

Constanța

Adapazarı

Ankara

ISTANBULt

Zonguldak

06202

Nice

115 27

Athens

455 00

Ioannina

41 110

Larissa

265 04

Pátrai

546 42

Thessaloniki

00149

Rome

00152

Rome

00161

Rome

00165

Rome

00189

Rome

09042

Cagliari

09100

Cagliari

07100

Sassari

11-236

Beirut

371 Tripoli

Tripoli

08117

Vilnius

08661

Vilnius

02990

Mexico City

P.O Box 35

Muscat

Lima 13

La Victoria, Lima

2805-267

Almada

2700-020

Amadora

3810-096

Aveiro

8000-386

Faro

1349-019

Lisbon

1649-035

Lisbon

4099-001

Porto

4202-451

Porto

P.O.Box 3051

Doha

021105

Bucharest

022328

Bucharest

975 17

Banská Bystrica

811 07

Bratislava

833 03

Bratislava

833 05

Bratislava

036 59

Martin

080 01

Prešov

00833

Kaohsiung City

01100

Adana

06100

Ankara

06290

Ankara

06800

Ankara

P.O.Box: 5735 - Sharjah, UAE

Sharjah city

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01675427 - A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C | Biotech Hunter | Biotech Hunter